The CASPIAN Phase III trial in extensive-stage small-cell lung cancer is the longest survival follow-up ever reported for immunotherapy treatment in this setting
Incorporating multi-modality image guidance, Ethos therapy provides the ability to personalize the patient's treatment based on their anatomy and position at the time of treatment
The designation is based on results from the EMPEROR-Preserved phase III trial, which established Jardiance as the first therapy to show statistically significant improvement in heart failure outcomes in adults with heart failure with a preserved ejection fraction
The company recently raised US $ 2.25 million seed round and the app was CE-Certified as a medical device in Europe
CDSCO-approved targeted therapy expands precision oncology options for patients with RET-driven lung, thyroid, and other advanced solid tumours
The company aims to make preventive and specialist healthcare as accessible as everyday retail experiences
As competition intensifies in the obesity treatment market, a next-generation therapy may be in development.
Approval makes it the first and only therapy in the EU indicated for both acute and chronic hepatitis C, supported by Phase 3 data
The findings come from the first and only decentralized real-world study examining how HD chorea affects patients and caregivers and how treatment impacts quality of life
Visakhapatnam-based hospital reaches major milestone in robotic orthopaedics, helping patients across North Andhra Pradesh and Odisha regain mobility through precision-assisted knee replacement procedures.
Subscribe To Our Newsletter & Stay Updated
